Ameriprise’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.9K | Sell |
|
|||||
|
2025
Q2 | $644K | Buy |
|
|||||
|
2025
Q1 | $23.1K | Buy |
|
|||||
|
2024
Q4 | $22.7K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $95K | Sell |
|
|||||
|
2022
Q3 | $52K | Buy |
|
|||||
|
2022
Q2 | $4K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $24K | Sell |
|
|||||
|
2021
Q3 | $44K | Sell |
|
|||||
|
2021
Q2 | $208K | Buy |
|
|||||
|
2021
Q1 | $69K | Buy |
|
|||||
|
2020
Q4 | $49K | Buy |
|
|||||
|
2020
Q3 | $43K | Sell |
|
|||||
|
2020
Q2 | $1.82M | Buy |
|
|||||
|
2020
Q1 | $295K | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q3 | $133K | Buy |
|
|||||
|
2019
Q2 | $140K | Sell |
|
|||||
|
2019
Q1 | $527K | Sell |
|
|||||
|
2018
Q4 | $1.15M | Buy |
|
|||||
|
2018
Q3 | $321K | Buy |
|
|||||
|
2018
Q2 | $196K | Sell |
|
|||||
|
2018
Q1 | $825K | Sell |
|
|||||
|
2017
Q4 | $2.5M | Buy |
|
|||||
|
2017
Q3 | $3.08M | Buy |
|
|||||
|
2017
Q2 | $1.22M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.41M | Buy |
|
|||||
|
2015
Q3 | $1.67M | Buy |
|